Xbrane

Xbrane Biopharma AB is a biotechnology company developing biosimilars, which are follow-on drugs to biologics that can be launched at a lower price after the original drug patents expire. Xbrane has a patented platform technology that provides lower production costs for biologics compared to other competitive systems. Xbrane has a team with specialized expertise capable of advancing biosimilars from cell lines to approval, with extensive collective experience in drug development.